RWMG
BCAB icon

Redwood Wealth Management Group’s BioAtla BCAB Stock Holding History

Redwood Wealth Management Group’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10
Closed -$685 – 253
2024
Q2 		$685 Buy
+10
New +$1.19K ﹤0.01% 1025

Other funds holding BCAB

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Redwood Wealth Management Group's BCAB Position: Q3 2024 in Review

Redwood Wealth Management Group sold out of BioAtla (BCAB) in Q3 2024, closing a stake of 10 shares — an estimated $685 sold.

Redwood Wealth Management Group first reported a position in BCAB in Q2 2024 and held it in 1 quarter. The position peaked at $685 in Q2 2024. 63 funds tracked by Wall St. Rank hold BCAB as of Q3 2024.

  • Redwood Wealth Management Group reported no remaining BioAtla position as of Q3 2024 after selling out during the quarter.
  • Redwood Wealth Management Group sold 10 BioAtla shares in Q3 2024, an estimated $685.
  • Redwood Wealth Management Group first reported a position in BioAtla in Q2 2024 and held it in 1 quarter.
  • Redwood Wealth Management Group's BioAtla position peaked at $685 in Q2 2024.
  • 63 funds tracked by Wall St. Rank held BioAtla as of Q3 2024.

Based on Redwood Wealth Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.